IFNG and anal carcinoma: Interferon-gamma (IFN-γ) is a key arbiter in inducing the anti-tumour effects of radiation, and given the role of MHC class I and PD-L1 in determining treatment response and outcomes for anal cancer patients [30–34], their expression was assessed by IHC and flow cytometry.